Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CAPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MESP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927735 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
WNK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC439911 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
MIR4454 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC643659 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPRKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FETUB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLC39A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH2D1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CATX-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on